Aclaris Therapeutics ACRS
NASDAQ ACRS
$5.26 -0.02 (-0.38%)
As of: Sep 30, 2026 · 10:23 AM EDT

Aclaris Therapeutics (ACRS) Total Current Liabilities (2014 - 2026)

Updated

Aclaris Therapeutics (ACRS) recorded Total Current Liabilities of $28.24 million in Q2 2026, up 5.2% from $26.84 million a year earlier and up 3.2% from the prior quarter.

Analysis

Aclaris Therapeutics (ACRS) Total Current Liabilities (2014 - 2026) Analysis & Trends

At the end of FY2025, Aclaris Therapeutics reported Total Current Liabilities of $28.65 million, down 9.3% from FY2024.

  • Annual Total Current Liabilities has a five-year compound annual growth rate of 14.0% (FY2020 to FY2025).
  • Across earlier years, Total Current Liabilities came in at $31.6 million in FY2024 (+2.1%), $30.95 million in FY2023 (+41.1%), $21.94 million in FY2022 (-4.3%) and $22.93 million in FY2021 (+54.2%).
  • Quarterly Total Current Liabilities has ranged from $15.68 million in Q2 2024 to $31.6 million in Q4 2024 over the past five years.
  • On a year-over-year basis, Total Current Liabilities rose in six of the last eight quarters, with growth averaging 13.6%.
  • Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 71.1% in Q2 2025, against a decline of 31.3% in Q2 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $27.37 million (Q1 2026), $28.65 million (Q4 2025) and $25.63 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Aclaris Therapeutics 759.25 Mn 759.25 Mn 1.41 Mn 28.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.24 Mn
Mar 31, 2026 27.37 Mn
Dec 31, 2025 28.65 Mn
Sep 30, 2025 25.63 Mn
Jun 30, 2025 26.84 Mn
Mar 31, 2025 21.51 Mn
Dec 31, 2024 31.60 Mn
Sep 30, 2024 18.82 Mn
Jun 30, 2024 15.68 Mn
Mar 31, 2024 20.08 Mn
Dec 31, 2023 30.95 Mn
Sep 30, 2023 27.32 Mn
Jun 30, 2023 22.83 Mn
Mar 31, 2023 18.26 Mn
Dec 31, 2022 21.94 Mn
Sep 30, 2022 19.79 Mn
Jun 30, 2022 16.22 Mn
Mar 31, 2022 16.73 Mn
Dec 31, 2021 22.93 Mn
Sep 30, 2021 17.84 Mn
API Access

Aclaris Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ACRS&period=max&api_key=YOUR_API_KEY